References
- BuistASMcBurnieMAVollmerWMBOLD Collaborative Research GroupInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
- EffingTKerstjensHvan der ValkPZielhuisGvan der PalenJ(Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II studyThorax2009641195696219736179
- NurmatovUBuckinghamSKendallMEffectiveness of holistic interventions for people with severe chronic obstructive pulmonary disease: systematic review of controlled clinical trialsPLoS One2012710e4643323110052
- ChettyMMacKenzieMDouglasGCurrieGPImmediate and early discharge for patients with exacerbations of chronic obstructive pulmonary disease: is there a role in “real life”?Int J Chron Obstruct Pulmon Dis20061440140718044096
- Jahnz-RozykKTargowskiTFromSCosts of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007 – results of multicenter Polish studyPol Merkur Lekarski200926153208214 Polish19388534
- NielsenRJohannessenABenediktsdottirBPresent and future costs of COPD in Iceland and Norway: results from the BOLD studyEur Respir J200934485085719357148
- OrnekTTorMAltinRClinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseInt J Med Sci20129428529022701335
- McGuireAIrwinDEFennPThe excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and WalesValue Health20014537037511705127
- PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
- DalalAAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534134921037958
- MiravitllesMMurioCGuerreroTGisbertRPharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPDChest200212151449145512006427
- FletcherCMElmesPCFairbairnASWoodCHThe significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working populationBMJ19592514725726613823475
- MullerovaHLuCTabbererMDisease burden of dyspnea in a primary care COPD populationAm J Respir Crit Care Med2012185A1518
- Clinical Practice Research Datalink Available from: http://www.cprd.com/home/Accessed October 4, 2012
- LeidyNKWilcoxTKJonesPWRobertsLPowersJHSethiSStandardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diaryAm J Respir Crit Care Med2011183332332920813886
- Gov.UK. Policy paperNHS reference costs 2010–2011 Available from: https://www.gov.uk/government/publications/2010-11-reference-costs-publicationAccessed October 4, 2012
- BuckinghamRJLoweDPurseyNARobertsCMStoneRAReport of the National Chronic Obstructive Pulmonary Disease Audit 2008: clinical audit of COPD exacerbations admitted to acute NHS units across the UK: Royal College of Physicians, British Thoracic Scoiety, British Lung Foundation2008 Available from: http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/COPD/NCROP/NCROPClinicalAudit.pdfAccessed November 17, 2013
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of COPD2010 Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdfAccessed November 17, 2012
- Personal Social Services Research UnitUnit Costs of Health and Social Care 2011 Available from: http://www.pssru.ac.uk/project-pages/unit-costs/2011/index.phpAccessed October 4, 2012
- British National Formulary 652012 Available from: http://bnf.org/bnf/index.htmAccessed October 4, 2012
- HertelNKotchieRWSamyshkinYRadfordMHumphreysSJamesonKCost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysisInt J Chron Obstruct Pulmon Dis2012718319922500119
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2006 Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport2006_0122.pdfAccessed October 4, 2012
- National Institute for Health and Care ExcellenceMedical Research Council dyspnea scale Available from: http://www.nice.org.uk/usingguidance/commissioningguides/pulmonaryrehabilitationserviceforpatientswithcopd/mrc_dyspnoea_scale.jspAccessed June 20, 2011
- HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- WoutersEFEconomic analysis of the Confronting COPD survey: an overview of resultsRespir Med200397Suppl CS3S1412647938
- SchermerTRSarisCGvan den BoschWJExacerbations and associated health care cost in patients with COPD in general practiceMonaldi Arch Chest Dis200665313314017220102
- SiafakasNMVermeirePPrideNBOptimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEur Respir J199588139814207489808
- AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
- TabbererMLuCMüllerovaHIncremental burden of dyspnea in COPD to a primary care COPD populationPresented at the Annual Congress of the American Thoracic SocietySan Francisco, CA, USAMay 18–23, 2012
- StrongMSouthGCarlisleRThe UK Quality and Outcomes Framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UKBMC Health Serv Res2009910819558719